TUBA1C and neoplasm: The overexpression of TUBA1C has been correlated with poor prognosis in patients with lung adenocarcinoma (LUAD) and is associated with 13 types of tumor-infiltrating immune cells (TIICs) in the tumor microenvironment [55].